Protagonist Therapeutics, Inc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PTGX Company Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
PTGX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PTGX Smart Score
Score Breakdown
PTGX Company Description
Show More
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PTGX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PTGX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on PTGX's company Twitter account
WallStreetBets
Number of mentions of PTGX in WallStreetBets Daily Discussion
PTGX News
Recent insights relating to PTGX
CNBC Recommendations
Recent picks made for PTGX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PTGX
Corporate Flights
Flights by private jets registered to PTGX
Our Analysis